Use of a claims-based active drug safety surveillance system to assess the risk of acute pancreatitis with exenatide or sitagliptin compared to metformin or glyburide

Kin-Wei Chan2018-09-102018-09-102009http://www.scopus.com/inward/record.url?eid=2-s2.0-67649304917&partnerID=MN8TOARShttp://scholars.lib.ntu.edu.tw/handle/123456789/345170[SDGs]SDG3Use of a claims-based active drug safety surveillance system to assess the risk of acute pancreatitis with exenatide or sitagliptin compared to metformin or glyburidejournal article10.1185/03007990902820519